We are live on ! Find out more
VCIM

Velan Capital Investment Management Portfolio holdings

AUM $160M
1-Year Est. Return 517.12%
This Fund
S&P 500
This Quarter Est. Return
+104.41%
1 Year Est. Return
+517.12%
3 Year Est. Return
+2,524.89%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$220M
AUM Growth
+$48.9M
Cap. Flow
-$3.47M
Cap. Flow %
-1.58%
Top 10 Hldgs %
90.34%
Holding
27
New
7
Increased
3
Reduced
4
Closed
6

Top Buys

Rank Stock Value
1
JSPR icon
Jasper Therapeutics
JSPR
+$6.22M
2
TELA icon
TELA Bio
TELA
+$4.41M
3
OTLK icon
Outlook Therapeutics
OTLK
+$4.04M
4
AQST icon
Aquestive Therapeutics
AQST
+$2M
5
MIST icon
Milestone Pharmaceuticals
MIST
+$1.06M

Top Sells

Rank Stock Value
1
IMGN
Immunogen Inc
IMGN
+$5.62M
2
ROIV icon
Roivant Sciences
ROIV
+$5.62M
3
LNTH icon
Lantheus
LNTH
+$4.65M
4
ADMA icon
ADMA Biologics
ADMA
+$3.32M
5
APLS
Apellis Pharmaceuticals
APLS
+$2.99M

Sector Composition

Rank Sector Weight
1 Healthcare 83.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ROIV icon
26
Roivant Sciences
ROIV
$26.1B
– –
-500,000
Closed -$5.62M
IMGN
27
DELISTED
Immunogen Inc
IMGN
– –
-189,500
Closed -$5.62M
1
2

Similar funds

BFAG
Blackston Financial Advisory Group The Villages, Florida $160M AUM 16.38% 1-Year Est. Return
SLG
Sanchez Levi Garrett $159M AUM
SMF
Sterling Manor Financial Saratoga Springs, New York $160M AUM 13.84% 1-Year Est. Return
LCA
Legend Capital Advisors New York $160M AUM
SGCM
Sanchez Gaunt Capital Management Reno, Nevada $160M AUM
RP
RIHO Partners Tucson, Arizona $159M AUM
PCC
Perry Creek Capital New York $160M AUM 3.05% 1-Year Est. Return
RCWM
Royal Capital Wealth Management Carmel, Indiana $161M AUM 18.42% 1-Year Est. Return

Velan Capital Investment Management's Q1 2024 Portfolio in Review

As of Q1 2024, Velan Capital Investment Management held 27 positions worth $220M, up 29% from $171M the previous quarter. Its ten largest holdings account for 90% of the portfolio.

Velan Capital Investment Management's Q1 2024 filing shows 7 new, 3 increased, 4 reduced and 6 closed positions. Its largest new stake was Outlook Therapeutics: 500,000 shares worth $5.97M. The largest sale was Immunogen Inc, an estimated $5.62M.

By sector, the portfolio is most concentrated in Healthcare at 84% of assets, up from 82% a quarter earlier.

  • Velan Capital Investment Management's largest Q1 2024 buy was Outlook Therapeutics: 500,000 shares worth $5.97M.
  • Velan Capital Investment Management added most to Jasper Therapeutics in Q1 2024, an estimated $6.22M increase.
  • Velan Capital Investment Management's biggest Q1 2024 reduction was ADMA Biologics, cutting an estimated $3.32M.
  • Velan Capital Investment Management fully exited Immunogen Inc in Q1 2024, selling an estimated $5.62M.
  • Velan Capital Investment Management's ten largest holdings make up 90% of its $220M portfolio in Q1 2024.
  • Velan Capital Investment Management opened 7 new positions and closed 6 in Q1 2024.
  • Velan Capital Investment Management's portfolio value rose 29% quarter-over-quarter to $220M.

Based on Velan Capital Investment Management's 13F filing for Q1 2024, filed 14 May 2024.